Accuracy:

The Tonocare has been through a rigorous testing protocol to compare closely to GAT. The heavy investment into the dynamic puff control enable the tonometer to produce accurate and consistent measurements which in turn will enable users to confidently monitor changes in IOP over time.

Affordability:

Our aim was to ensure all clinicians all over the world could afford to use the device with little burdening costs on either their practise or the patient, inherently this would ensure detection of the second leading cause blindness to increase.